Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Watch Anglo American (AAL) by Cliff D'Arcy in The Motley Fool
- Avoid ActiveOps (AOM) by Steve Moore in ShareProphets
- Overweight Relx plc (REL) by JP Morgan
- Avoid SRT Marine Systems (SRT) by Steve Moore in ShareProphets
- Sell WPP (WPP) by UBS
- Buy NextEnergy Solar Fund Limited Red (NESF) by Gaurav Sharma in The Motley Fool
- Buy Octopus Renewables Infrastructure Trust (ORIT) by Gaurav Sharma in The Motley Fool
- Buy The Renewables Infrastructure Group Limited (TRIG) by Gaurav Sharma in The Motley Fool
- Buy Aviva (AV.) by Christopher Ruane in The Motley Fool
- Buy Legal & General Group (LGEN) by Christopher Ruane in The Motley Fool
- Buy Persimmon (PSN) by Paul Summers in The Motley Fool
- Hold Anglo American (AAL) by DZ Bank
- Buy Unilever (ULVR) by Stephen Wright in The Motley Fool
- Neutral Unilever (ULVR) by Goldman Sachs
- Buy British American Tobacco (BATS) by Charlie Keough in The Motley Fool
- Sector Perform Unilever (ULVR) by RBC Capital
- Buy Anglo Asian Mining (AAZ) by Hot Stock Rockets in ShareProphets
- Buy Croda International (CRDA) by UBS
- Avoid Videndum (VID) by Steve Moore in ShareProphets
- Buy Reckitt Benckiser Group (RKT) by DZ Bank
Diurnal Group (DNL) Share Price
Health Care Sector
NOTE: This is based on 7 open tips for Diurnal Group (DNL)
| Latest Bid : 27.10p | Latest Ask : 27.50p |
| High Today : 27.30p | Low Today : 27.30p |
| This Years High : 66.50p | This Years Low : 9.75p |
| Volume : 145,284 | MKT Cap : £46.14M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Diurnal Group (DNL) Overview
Diurnal Group plc is a European, UK-headquartered specialty pharmaceutical company dedicated to developing hormone therapeutics to aid lifelong treatment for rare and chronic endocrine conditions, including Congenital Adrenal Hyperplasia, Adrenal Insufficiency, Hypogonadism and Hypothyroidism.Diurnal Group (DNL) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Steve Moore | Premium Only | 2022-04-04 12:15:00 04/04/2022 | -79.02% |
| Sell | Steve Moore | Premium Only | 2022-03-22 13:30:00 22/03/2022 | -60.59% |
| Buy | Sabah Meddings | Premium Only | 2020-10-11 10:35:00 11/10/2020 | -56.32% |
| Buy | Peter Stephens | Premium Only | 2018-03-12 13:05:00 12/03/2018 | -69.34% |
| Buy | Numis | Premium Only | 2018-02-13 08:00:00 13/02/2018 | 3.60% |
Diurnal Group (DNL) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 27.10p | Latest Ask : 27.50p |
| High Today : 27.30p | Low Today : 27.30p |
| This Years High : 66.50p | This Years Low : 9.75p |
| Volume : 145,284 | MKT Cap : £46.14M |
Diurnal Group Overview
Diurnal Group plc is a European, UK-headquartered specialty pharmaceutical company dedicated to developing hormone therapeutics to aid lifelong treatment for rare and chronic endocrine conditions, including Congenital Adrenal Hyperplasia, Adrenal Insufficiency, Hypogonadism and Hypothyroidism.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Diurnal Group Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Steve Moore | Premium Only | 2022-04-04 12:15:00 04/04/2022 | -79.02% |
| Sell | Steve Moore | Premium Only | 2022-03-22 13:30:00 22/03/2022 | -60.59% |
| Buy | Sabah Meddings | Premium Only | 2020-10-11 10:35:00 11/10/2020 | -56.32% |
| Buy | Peter Stephens | Premium Only | 2018-03-12 13:05:00 12/03/2018 | -69.34% |
| Buy | Numis | Premium Only | 2018-02-13 08:00:00 13/02/2018 | 3.60% |